HPLC Separation of Active Compounds in Drug Formulation

HPLC-Applikation • Datum: 2005/01/13
HPLC Separation of Active Compounds in Drug Formulation Chromatogramm

An HPLC method for the separation of active drug compounds on a Primesep 200 column. The retention of compounds is achieved through reverse-phase, cation exchange and hydrophobic interactions. Benzoic acid, hyoscyamine sulfate and phenyl salicylate are baseline separated using simple mobile phases of water, acetonitrile (MeCN, ACN) and trifluoroacetic acid (TFA) with a UV detector.

Methodenparameter

ColumnPrimesep 200, 3.0×50 mm, 5 µm, 100 Å
Mobile PhaseMeCN/H2O
BufferTFA
Flow Rate1.0 mL/min
DetectionUV, 220 nm